Market Place
Sourcing Support
Inke unveils its New Brand Identity reflecting Growth and Innovation
05 Sep 2024 //
PRESS RELEASE
Neuraxpharm agrees on divestment of inhalation API specialist Inke to Keensight
12 Jun 2024 //
PRESS RELEASE
INKE increases its production capacity with the support of ACCIÓ
06 Jun 2024 //
PRESS RELEASE
Clifford Chance advises on the financing for Keensight Capital’s acquisition of Inke
21 Jun 2023 //
IBERIANLAWYER
Neuraxpharm announces closing of acquisition of established products from Sanofi
01 Feb 2023 //
PR NEWSWIRE
Neuraxpharm completes its presence in Benelux by opening an affiliate
24 Jan 2023 //
PR NEWSWIRE
Neuraxpharm launches European campaign to increase awareness of medical cannabis
19 Oct 2022 //
PR NEWSWIRE
Neuraxpharm to increase branded business through upcoming acquisition from Sanofi
12 Jul 2022 //
PR NEWSWIRE
Inke to triple capacity for inhalation API manufacturing
20 Apr 2022 //
PRESS RELEASE
Leading inhalation APIs expert Inke to triple production capacity
20 Apr 2022 //
PRNEWSWIRE
Panaxia & Neuraxpharm: First export of medical cannabis sublingual tab to France
24 Jan 2022 //
PR NEWSWIRE
Neuraxpharm appoints commercial expert Dr. Maximilian von Wülfing COF
01 Jun 2021 //
PRNEWSWIRE
Neuraxpharm establishes operations in the Republic of Ireland the acquisition
14 Dec 2020 //
PRNEWSWIRE
Neuraxpharm acquires market-leading value-added product for emergency
14 Sep 2020 //
PRNEWSWIRE
Nupharm Group Rebrands To Neuraxpharm
10 Feb 2018 //
PRESS RELEASE
Funds advised by Apax Partners to acquire the operating subsidiaries of Invent
08 Jun 2016 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.